Blog
COVID-19 breakthrough infection rates by co-morbidity during Omicron wave
A first look at Truveta at #ViVE2022 – and taking on the big challenge of building trust in medical insights
Today in a keynote at ViVE, I unveiled the Truveta platform for the first time with its first public demonstration. While preparing for this keynote, I…
Understanding post-Covid-19 infection incidents of heart inflammation in hospitalized patients
COVID-19: Which vaccines are people getting?
Percent of COVID-19 hospitalizations decreasing
Partnering to improve data quality and health equity
Truveta and Lexis Nexis Risk Solutions partner to create the most complete, highest quality U.S. public health data platform 2022 is off to a rough start…
Reflecting on 2021
2021 was another incredible year. Our world continues to be different in so many ways as the effects of COVID-19 continue to challenge us. It has…
Introducing the Truveta platform and new COVID-19 insights
Today I am excited to introduce the Truveta Platform for health systems and life science companies, share new insights about COVID-19 from the Truveta Platform,…